Exendin-9,39 and Satiety After Bariatric Surgery

Completed · Not applicable

Conditions studied: Obesity

In brief

The overall aim of the application is to determine the contribution of the elevated incretin hormone concentrations seen after certain types of bariatric surgery to the regulation of food intake and satiety.

Key facts

Study ID

NCT02779075

Run by

Mayo Clinic

People needed

29

Starts

2016-06-01

Expected to finish

2019-12-01

Last updated by the study team

2020-05-01

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Undergone either sleeve gastrectomy or Roux-en-Y Gastric Bypass surgery within prior 2 years
• Healthy, with no active systemic illness

You may not qualify if…

• Pregnancy
• Functional or organic bowel symptoms
• Systemic illness
• Diabetes
• Bariatric surgery > 2 years

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.